# OnCo record paper-lau-time-limited-recommendation-ptap-curr-oncol-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lau-time-limited-recommendation-ptap-curr-oncol-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lau-time-limited-recommendation-ptap-curr-oncol-2025" ;
  schema:name "Accelerating oncology drug reimbursement in Canada: the time-limited recommendation and temporary access process"@en ;
  schema:description "Canada's 2023 fast lane for conditionally licensed cancer drugs, in which value review and price negotiation run side by side, got the first drug to use it to its first province more than 200 days sooner than a similar drug on the ordinary route."@en ;
  schema:url <https://onco.cc/key-papers/paper-lau-time-limited-recommendation-ptap-curr-oncol-2025/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.3390/curroncol32040235>, <https://pubmed.ncbi.nlm.nih.gov/40277790/> ;
  schema:sameAs <https://doi.org/10.3390/curroncol32040235> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Lau CY, Mitha A, Wills A" ;
  onco:institutions <https://onco.cc/institutions/cda-amc/>, <https://onco.cc/institutions/health-canada/> ;
  onco:journals <https://onco.cc/journals/current-oncology-mdpi/> .